Rosiglitazone and glimepiride vs CYP2C8 Inhibitors (Moderate)

Interacting Drugs
Rosiglitazone and glimepiride
vs
CYP2C8 Inhibitors (Moderate)
Security Level
Minor, Monitor Therapy
Mechanism
CYP2C8 Inhibitors (Moderate): May decrease the metabolism of CYP2C8 Substrates (High risk).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Rosiglitazone and glimepiride vs CYP2C8 Inhibitors (Moderate)


Other Interactions of Rosiglitazone and glimepiride

We are Developing Our database, More results coming soon.

Other Interactions of CYP2C8 Inhibitors (Moderate)

We are Developing Our database, More results coming soon.